ArticleEuropean journal of breast health2026
Baseline Quality of Life and Its Predictors among Jordanian Women with Breast Cancer: Findings from an Ongoing Randomized Controlled Trial.
Article in European journal of breast health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Breast cancer is the most common cancer among women in Jordan. Survivors often experience impaired quality of life (QoL) due to various sociodemographic and clinical factors. Understanding QoL at the time of diagnosis is essential for developing effective interventions. This study aimed to assess baseline QoL and to identify predictors of QoL among Jordanian women with breast cancer prior to any intervention. Materials and Methods: This cross-sectional analysis examined baseline data from an ongoing randomized controlled trial registered with Australian New Zealand clinical trials registry. Two hundred women with breast cancer completed the Arabic versions of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and EORTC QLQ-BR23 questionnaires at study entry, prior to randomization and intervention. Sociodemographic and clinical variables were collected and analyzed using SPSS version 24. Multiple regression analysis was performed to identify predictors of QoL. Results: The mean age of participants was 48.0±8.3 years. The global QoL score was 57.4/100. Higher scores were observed for role and social functioning, whereas emotional functioning had the lowest scores. The most frequently reported symptoms were insomnia, fatigue, and pain multivariate linear regression identified younger age (positively associated) and total breast symptoms (negatively associated) as significant independent predictors of QLQ-C30 global QoL. For QLQ-BR23, the overall model was significant, although no individual predictor reached statistical significance. Conclusion: Jordanian women with breast cancer experience moderate impairment in QoL at study entry, primarily influenced by symptom burden and age. These baseline findings provide a foundation for interpreting intervention effects in the ongoing randomized controlled trial. Routine assessment of symptoms and culturally sensitive supportive care are recommended to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.